EDGAR Filing Documents for 0001493152-18-011124

Form 8-K - Current report:

SEC Accession No. 0001493152-18-011124

Filing Date

2018-08-08

Accepted

2018-08-08 07:00:50

Documents

Period of Report

2018-08-08

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	25948
2		ex99-1.htm	EX-99.1	19650
3		ex99-1_001.jpg	GRAPHIC	97089
4		ex99-1_002.jpg	GRAPHIC	254446
5		ex99-1_003.jpg	GRAPHIC	127835
6		ex99-1_004.jpg	GRAPHIC	83602
7		ex99-1_005.jpg	GRAPHIC	87572
8		ex99-1_006.jpg	GRAPHIC	159943
9		ex99-1_007.jpg	GRAPHIC	166572
10		ex99-1_008.jpg	GRAPHIC	194014
11		ex99-1_009.jpg	GRAPHIC	83096
12		ex99-1_010.jpg	GRAPHIC	131565
13		ex99-1_011.jpg	GRAPHIC	160236
14		ex99-1_012.jpg	GRAPHIC	146699
15		ex99-1_013.jpg	GRAPHIC	143202
16		ex99-1_014.jpg	GRAPHIC	23995
17		ex99-1_015.jpg	GRAPHIC	180416
18		ex99-1_016.jpg	GRAPHIC	147439
19		ex99-1_017.jpg	GRAPHIC	36491
20		ex99-1_018.jpg	GRAPHIC	270838
21		ex99-1_019.jpg	GRAPHIC	105156
22		ex99-1_020.jpg	GRAPHIC	113045
23		ex99-1_021.jpg	GRAPHIC	287170
24		ex99-1_022.jpg	GRAPHIC	259680
	Complete submission text file	0001493152-18-011124.txt		4538585

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)